Effects of Systemic Drugs on Intraocular Pressure
NCT05328921 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2022-04-14
Summary
To assess intraocular pressure changes among glaucoma patients on systemic antihypertensive and antihistaminic drugs.
Conditions
- Glaucoma, Angle-Closure
- Glaucoma Suspect
- Glaucoma Secondary to Drugs, Bilateral
- Hypertension
Interventions
- DRUG
-
Antihypertensive Agents
Patients with narrow angle glaucoma and on systemic antihypertensive drugs.
- DRUG
-
Antihistaminics
Patients with narrow angle glaucoma and on systemic antihistaminic drugs.
Sponsors & Collaborators
-
Benha University
lead OTHER
Eligibility
- Min Age
- 35 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-07
- Primary Completion
- 2022-09-15
- Completion
- 2022-09-30
Countries
- Egypt
Study Locations
More Related Trials
-
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
NCT00051194 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Preference Study
NCT00576342 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00326092 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT02339584 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
NCT00168363 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure
NCT00683501 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
NCT02003534 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
NCT06270030 ·Status: COMPLETED ·Phase: PHASE1
-
The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma
NCT04205201 ·Status: COMPLETED ·Phase: PHASE2
-
MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)
NCT00449956 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
NCT01297517 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)
NCT00108017 ·Status: COMPLETED ·Phase: PHASE3
-
Equivalence Study of Dorzolamide 2% Eye Drops Solution
NCT00878917 ·Status: COMPLETED ·Phase: PHASE3
-
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
NCT05022004 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00314158 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
NCT07209410 ·Status: RECRUITING ·Phase: PHASE4
-
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
NCT01309204 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
NCT00069719 ·Status: COMPLETED ·Phase: PHASE2
-
Mirtogenol and Bimatoprost on IOP in Hispanics With Open-Angle Glaucoma
NCT04380025 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of a Drug Delivery System in Glaucoma
NCT01016691 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
NCT05045248 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension
NCT03310580 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.
NCT00595101 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
NCT03233308 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00314171 ·Status: COMPLETED ·Phase: PHASE3